Stanich Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Buy
252
+17
+7% +$17.4K 0.19% 38
2026
Q1
$216K Hold
235
0.16% 43
2025
Q4
$253K Buy
+235
New +$225K 0.19% 38

Other funds holding LLY

Stanich Group's LLY Position: Q2 2026 in Review

Stanich Group increased its Eli Lilly (LLY) stake by 7.2% in Q2 2026, buying an estimated $17.4K and bringing the position to 252 shares worth $302K. The position accounts for 0.19% of the portfolio, ranked #38.

Stanich Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,085 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stanich Group held 252 shares of Eli Lilly worth $302K as of Q2 2026.
  • Stanich Group bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 0.19% of Stanich Group's portfolio in Q2 2026, its #38 holding.
  • Stanich Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,085 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stanich Group's 13F filing for Q2 2026, filed 16 Jul 2026.